|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K2299/00 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| A61K 47/50 | (2017.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61K 31/5365 | (2006.01) | ||
| C07K2317/33 | (2013.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/77 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| A61K 47/6803 | (2017.08) | ||
| A61K 47/6849 | (2017.08) | ||
| A61K 47/6851 | (2017.08) | ||
| C07K 16/28 | (2013.01) | ||
| A61K 31/5365 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3218410 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15798251.3 |
| Date of filing the European patent application | 2015-11-13 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/058801 |
| Date | 2015-11-13 |
| (87) | Number | WO 2016/075670 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 201462079942 P | 2014-11-14 | US |
| (72) |
ABRAMS, Tinya , US
COHEN, Steven , US
DAMIANO, Jason , US
DÜRR, Clemens , CH
HUBER, Thomas , CH
MENEZES, Daniel , US
MILLER, Kathy , US
RENDAHL, Katherine , US
RONDEAU, Jean-michel Rene , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | ANTIBODY DRUG CONJUGATES |
| ANTIBODY DRUG CONJUGATES |